Whats the estimate of value of the PSID's patent, proprietary and disruptive technology in a $27 billion market 'Point of Care' clinical testing market...also it is this market that is growing at 8.4% per year at least to 2024. Of course this pie of $27 Billion market is sliced into pieces for certain segments of testing. Just to be conservative, lets say 40% is what the "Firefly" can disrupt...that's $ 10.8 Billion. IMO, outright they could sell for $100 million....wait 6 months to a 1 year after release with proof of expected revenues, they could get $200-$300 million. Outstanding shares are super low...no way they are going to reverse split again...For what purpose? Shares will be scarce soon and this stock will see 'silver' within 3 months, imo.
